The TRACTISS protocol:a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome
Abstract
Abstract is not available.- article
- Antibodies, Monoclonal, Murine-Derived
- B-Lymphocytes
- Biological Markers
- Clinical Protocols
- Disease Progression
- Double-Blind Method
- Drug Administration Schedule
- Female
- Great Britain
- Humans
- Immunologic Factors
- Infusions, Intravenous
- Male
- Quality of Life
- Research Design
- Salivation
- Sjogren's Syndrome
- Tears
- Time Factors
- Treatment Outcome